Immunotherapy for hepatocellular carcinoma: current status and future perspectives

Autor Okusaka, Takuji, Ikeda, Masafumi
Vydáno v ESMO Open (2018)

Successful obliteration of bleeding duodenal varices by EUS-guided injection of N-butyl-2-cyanoacrylate

Autor Kimura, Gen, Hashimoto, Yusuke, Ikeda, Masafumi
Vydáno v VideoGIE (2017)

Endoscopic unroofing drainage with a needle-knife for gastric wall abscess: a rare adverse event that developed after EUS-FNA

Autor Kimura, Gen, Hashimoto, Yusuke, Ikeda, Masafumi
Vydáno v VideoGIE (2019)

New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer

Autor Imaoka, Hiroshi, Sasaki, Mitsuhito, Hashimoto, Yusuke, Watanabe, Kazuo, Ikeda, Masafumi
Vydáno v J Clin Med (2019)

Phase I study of TAC‐101, an oral synthetic retinoid, in Japanese patients with advanced hepatocellular carcinoma

Autor Okusaka, Takuji, Ueno, Hideki, Ikeda, Masafumi, Takezako, Yoriko, Morizane, Chigusa
Vydáno v Cancer Sci (2012)

Hepatitis B Virus Reactivation during Treatment with Multi-Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma

Autor Shiba, Satoshi, Kondo, Shunsuke, Ueno, Hideki, Morizane, Chigusa, Ikeda, Masafumi, Okusaka, Takuji
Vydáno 2012

Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives

Autor Hijioka, Susumu, Morizane, Chigusa, Ikeda, Masafumi, Ishii, Hiroshi, Okusaka, Takuji, Furuse, Junji
Vydáno v Jpn J Clin Oncol (2021)

Treatment of hepatocellular carcinoma during the COVID‐19 outbreak: The Working Group report of JAMTT‐HCC

Autor Kudo, Masatoshi, Kurosaki, Masayuki, Ikeda, Masafumi, Aikata, Hiroshi, Hiraoka, Atsushi, Torimura, Takuji, Sakamoto, Naoya
Vydáno v Hepatol Res (2020)

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer

Autor Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Vydáno v Cancer Sci (2014)

Response to Y. Sasaki et al.: Is repeating FOLFIRINOX in the original dosage and treatment schedule tolerable in Japanese patients with pancreatic cancer?

Autor Okusaka, Takuji, Ikeda, Masafumi, Fukutomi, Akira, Ioka, Tatsuya, Furuse, Junji, Ohkawa, Shinichi, Isayama, Hiroyuki, Boku, Narikazu
Vydáno v Cancer Sci (2015)

Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future

Autor Ikeda, Masafumi, Mitsunaga, Shuichi, Ohno, Izumi, Hashimoto, Yusuke, Takahashi, Hideaki, Watanabe, Kazuo, Umemoto, Kumiko, Okusaka, Takuji
Vydáno v Diseases (2015)

Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: study protocol for an open-label, multicentre, prospective phase II tr...

Autor Takahashi, Shinichiro, Ohno, Izumi, Ikeda, Masafumi, Kobayashi, Tatsushi, Akimoto, Tetsuo, Kojima, Motohiro, Konishi, Masaru, Uesaka, Katsuhiko
Vydáno v BMJ Open (2017)

Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety‐Assessment Cohort

Autor Doi, Toshihiko, Fujiwara, Yutaka, Koyama, Takafumi, Ikeda, Masafumi, Helwig, Christoph, Watanabe, Morihiro, Vugmeyster, Yulia, Kudo, Masatoshi
Vydáno v Oncologist (2020)

Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis

Autor Imaoka, Hiroshi, Sasaki, Mitsuhito, Hashimoto, Yusuke, Watanabe, Kazuo, Miyazawa, Shoichi, Shibuki, Taro, Mitsunaga, Shuichi, Ikeda, Masafumi
Vydáno v Diagnostics (Basel) (2021)

A phase 1b study of transforming growth factor-beta receptor I inhibitor galunisertib in combination with sorafenib in Japanese patients with unresectable hepatocellular carcinoma

Autor Ikeda, Masafumi, Morimoto, Manabu, Tajimi, Masaomi, Inoue, Koichi, Benhadji, Karim A., Lahn, Michael M. F., Sakai, Daisuke
Vydáno v Invest New Drugs (2018)

Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial

Autor Terazawa, Tetsuji, Kondo, Shunsuke, Hosoi, Hiroko, Morizane, Chigusa, Shimizu, Satoshi, Mitsunaga, Shuichi, Ikeda, Masafumi, Ueno, Hideki, Okusaka, Takuji
Vydáno 2014

Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma

Autor Ikeda, Masafumi, Ohkawa, Shinichi, Okusaka, Takuji, Mitsunaga, Shuichi, Kobayashi, Satoshi, Morizane, Chigusa, Suzuki, Ikue, Yamamoto, Shunsuke, Furuse, Junji
Vydáno v Cancer Sci (2014)

Everolimus for Advanced Pancreatic Neuroendocrine Tumours: A Subgroup Analysis Evaluating Japanese Patients in the RADIANT-3 Trial

Autor Ito, Tetsuhide, Okusaka, Takuji, Ikeda, Masafumi, Igarashi, Hisato, Morizane, Chigusa, Nakachi, Kohei, Tajima, Takeshi, Kasuga, Akio, Fujita, Yoshie, Furuse, Junji
Vydáno 2012

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer

Autor Suzuki, Eiichiro, Ikeda, Masafumi, Okusaka, Takuji, Nakamori, Shoji, Ohkawa, Shinichi, Nagakawa, Tatsuya, Boku, Narikazu, Yanagimoto, Hiroaki, Sato, Tosiya, Furuse, Junji
Vydáno 2013

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Autor Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Vydáno 2013